Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2

Texto completo
Autor(es):
Rego, Gabriel N. A. [1] ; Nucci, Mariana P. [2] ; Alves, Arielly H. [1] ; Oliveira, Fernando A. [1] ; Marti, Luciana C. [1] ; Nucci, Leopoldo P. [3] ; Mamani, Javier B. [1] ; Gamarra, Lionel F. [1]
Número total de Autores: 8
Afiliação do(s) autor(es):
[1] Hosp Israelita Albert Einstein, BR-05652900 Sao Paulo - Brazil
[2] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, LIM44, BR-01246903 Sao Paulo - Brazil
[3] Ctr Univ Planalto, Cent UNICEPLAC, BR-72445020 Brasilia, DF - Brazil
Número total de Afiliações: 3
Tipo de documento: Artigo de Revisão
Fonte: VACCINES; v. 8, n. 3 SEP 2020.
Citações Web of Science: 1
Resumo

Coronavirus disease 2019 (COVID-19) is the biggest health challenge of the 21st century, affecting millions of people globally. The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has ignited an unprecedented effort from the scientific community in the development of new vaccines on different platforms due to the absence of a broad and effective treatment for COVID-19 or prevention strategy for SARS-CoV-2 dissemination. Based on 50 current studies selected from the main clinical trial databases, this systematic review summarizes the global race for vaccine development against COVID-19. For each study, the main intervention characteristics, the design used, and the local or global center partnerships created are highlighted. Most vaccine developments have taken place in Asia, using a viral vector method. Two purified inactivated SARS-CoV-2 vaccine candidates, an mRNA-based vaccine mRNA1273, and the chimpanzee adenoviral vaccine ChAdOx1 are currently in phase III clinical trials in the respective countries Brazil, the United Arab Emirates, the USA, and the United Kingdom. These vaccines are being developed based on a quickly formed network of collaboration. (AU)

Processo FAPESP: 14/50983-3 - INCT 2014: fluidos complexos
Beneficiário:Antonio Martins Figueiredo Neto
Modalidade de apoio: Auxílio à Pesquisa - Temático